The management of schizophrenia: focus on extended-release quetiapine fumarate

por Peuskens, Joseph
Publicado 2011

Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice

por Peuskens, Joseph, Rubio, Gabriel, Schreiner, Andreas
Publicado 2014

Schizophrenia symptoms and functioning in patients receiving long-term treatment with olanzapine long-acting injection formulation: a pooled analysis

por Peuskens, Joseph, Porsdal, Vibeke, Pecenak, Jan, Handest, Peter, D'yachkova, Yulia, Brousil, Radim, Deberdt, Walter
Publicado 2012

Treatment response, safety, and tolerability of paliperidone extended release treatment in patients recently diagnosed with schizophrenia

por Helldin, Lars, Peuskens, Joseph, Vauth, Roland, Sacchetti, Emilio, bij de Weg, Haye, Herken, Hasan, Lahaye, Marjolein, Schreiner, Andreas
Publicado 2015

Prevalence and severity of antipsychotic related constipation in patients with schizophrenia: a retrospective descriptive study

por De Hert, Marc, Dockx, Liesbeth, Bernagie, Chiara, Peuskens, Bie, Sweers, Kim, Leucht, Stefan, Tack, Jan, Van de Straete, Stefan, Wampers, Martien, Peuskens, Joseph
Publicado 2011

Effectiveness of injectable risperidone long-acting therapy for schizophrenia: data from the US, Spain, Australia, and Belgium

por Lambert, Tim, Olivares, José M, Peuskens, Joseph, DeSouza, Cherilyn, Kozma, Chris M, Otten, Patrick, Crivera, Concetta, Jacobs, An, Macfadden, Wayne, Mao, Lian, Rodriguez, Stephen C, Dirani, Riad, Akhras, Kasem S
Publicado 2011